Syndax Pharmaceuticals Inc Annual Depreciation in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Syndax Pharmaceuticals Inc annual Depreciation history and growth rate from 2014 to 2023.
  • Syndax Pharmaceuticals Inc annual Depreciation for 2023 was $12M, a 63.6% decline from 2022.
  • Syndax Pharmaceuticals Inc annual Depreciation for 2022 was $33M, a 23.3% decline from 2021.
  • Syndax Pharmaceuticals Inc annual Depreciation for 2021 was $43M, a 47678% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12M -$21M -63.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $33M -$10M -23.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $43M +$42.9M +47678% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $90K -$2K -2.17% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $92K +$14K +17.9% Jan 1, 2019 Dec 31, 2019 10-K 2020-03-05
2018 $78K +$2K +2.63% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-05
2017 $76K -$13K -14.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-05
2016 $89K +$68K +324% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
2015 $21K +$6K +40% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $15K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.